ZIOPHARM Oncology Inc (USD)
ZIOP
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range4.74 | 5.08
52-Wk Range1.56 | 7.25
Last Close5.08
Mkt Cap (m)919.63
Dividend yield-
ISINUS98973P1012
Volume1,999,623
Exchange VenueNAS

Company Profile

ZIOPHARM Oncology Inc is a biotechnology company which acquires, develops, and commercializes cancer therapies that can address unmet medical needs through synthetic biology.

Key Information
Price/Earning6.77
Price/Book8.67
Price/Sales-
P/CF-
Rev Growth (3 year avg)-67.70
EPS Growth (3 year avg)-
Operating Margin % -36921.92
Net Margin %-36381.51
Return on Equity-
Debt/Equity-

Legal Documents

Prospectus
en 23/10/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)11476
Operating Income (m)-58-43-120-165-53-54
Net Income (m)-57-32-120-165-54-53
Basic EPS-0.66-0.31-0.96-1.32-0.530.96
Avg. Diluted Shares Outstanding (m)86101125130137144
Balance Sheet
USD201320142015201620172018
Current Assets (m)70441531059184
Non Current Assets (m)11111511
Total Assets (m)724515410610695
Current Liabilities (m)8111816219
Total Liabilities (m)------
Total Equity (m)493487-77-9786
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-60-37-58-55-49
Capital Expenditure (m)-1-1
Figures are quoted in USD unless stated otherwise
-0.24 (-4.72%)
$
4.84
Last Price